Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study

BACKGROUND: There is no consensus regarding the optimal time to initiate adjuvant chemotherapy after surgery for stage III colon cancer, and the relevant postoperative complications that cause delays in adjuvant chemotherapy are unknown. METHODS: Eligible patients aged ≥66 years who were diagnosed w...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Peng, Huang, Xuan-zhang, Song, Yong-xi, Sun, Jing-xu, Chen, Xiao-wan, Sun, Yu, Jiang, Yu-meng, Wang, Zhen-ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831576/
https://www.ncbi.nlm.nih.gov/pubmed/29490625
http://dx.doi.org/10.1186/s12885-018-4138-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831576/
https://www.ncbi.nlm.nih.gov/pubmed/29490625
http://dx.doi.org/10.1186/s12885-018-4138-7

Ejemplares similares